By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 Speen Street, Suite 306

Framingham  Massachusetts   01701  U.S.A.
Phone: 508-861-7709 Fax: n/a


Key Statistics

Ownership: Private

Web Site: Alzheon


Company News
Alzheon Appoints Dennis H. Langer, MD, JD, To Board Of Directors 3/11/2016 10:09:52 AM
Alzheon Wants Another Shot at Alzheimer's, Presents Data for Tweaked Phase III Studies on Once-Rejected Drug Tramiprosate 3/11/2016 6:13:58 AM
Top 20 Life Science Startups to Watch in the U.S. 1/26/2016 7:46:23 AM
What You Need to Know About Alzheon 12/17/2015 11:27:21 AM
Alzheon Appoints Former GlaxoSmithKline (GSK) CEO Jean-Pierre Garnier As Chairman Of Board Of Directors 12/10/2015 10:36:27 AM
Alzheon Announces Presentations At Two Upcoming Investor Conferences 11/12/2015 11:40:52 AM
Alzheon Announces Initiation Of Clinical Studies With ALZ-801 Bridging To Pivotal Phase 3 Study In Alzheimer’s Disease 11/6/2015 11:11:38 AM
Alzheon Announces Efficacy Outcomes From Two Prior Tramiprosate Phase 3 Studies 11/6/2015 11:06:31 AM
Alzheon To Present Late-Breaking Presentation At 8th Clinical Trials On Alzheimer’s Disease Congress 10/27/2015 10:28:21 AM
Alzheon To Present At The 2015 Ladenburg Thalmann Healthcare Conference 9/29/2015 11:01:56 AM